Myocardial protection during percutaneous transluminal coronary angioplasty

J M Lasala1, M W Cleman

  • 1Yale University School of Medicine, New Haven, Connecticut.

Cardiology Clinics
|August 1, 1988
PubMed

Insights

Coronary angioplasty causes temporary artery blockage, leading to myocardial ischemia. This review covers methods to prevent the electrical and blood flow issues arising from this ischemia.

Area of Science:

  • Cardiology
  • Cardiovascular Research
  • Interventional Cardiology

Background:

  • Coronary angioplasty is a common procedure for treating coronary artery disease.
  • The procedure involves temporary occlusion of coronary arteries, inducing regional myocardial ischemia.
  • Myocardial ischemia can lead to significant electrophysiologic and hemodynamic disturbances.

Purpose of the Study:

  • To review systemic and regional methods for preventing adverse outcomes of transient coronary artery occlusion during angioplasty.
  • To provide an overview of current strategies to mitigate ischemia-related complications.
  • To consolidate knowledge on managing the consequences of procedural ischemia.

Main Methods:

  • Review of existing literature on systemic and regional protective strategies.
  • Analysis of studies investigating the prevention of electrophysiologic changes.
  • Evaluation of methods aimed at preserving hemodynamic function during ischemia.

Main Results:

  • Identified various systemic approaches, including pharmacological interventions.
  • Highlighted regional protective techniques, such as specific reperfusion strategies.
  • Summarized the efficacy of different methods in preventing arrhythmias and maintaining cardiac output.

Conclusions:

  • Effective prevention strategies for electrophysiologic and hemodynamic consequences are crucial for safe angioplasty.
  • Both systemic and regional methods offer potential benefits in managing ischemia.
  • Further research may refine these protective measures for improved patient outcomes.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...